Decoding tumour complexity to design better treatments.
At HeteroGenesys we’re transforming cancer research with a cost-effective, clinically-relevant alternative to animal models and established cell cultures.
OUR SERVICES
Revolutionising Brain Research Alternatives
HeteroGenesys are a team of academics and clinicians from The University of Sheffield, developing our novel platform for heterogeneous cancer research and conducting market discovery through the BBSRC-NC3Rs-ICURe programme.
Our goal is refine a robust, versatile, and translatable in vitro tool to encapsulate tumour heterogeneity and improve predictive power of pre-clinical research. We hope to provide tissue and cell-based resources, an ancillary multi-omics data bank, and expert tailored consultancy.
Platform
The HeteroGenesys Platform Empowers
Integrating our platform into your research unlocks actionable insights, appreciating the full complexity of tumour biology – paving the way for better informed decision-making, increased efficiency, and more confidence in translatability of generated data.
Big Pharma
Improving predictive power of trial success in early stages, unlocking precision in patient stratification, and bypassing regulatory hurdles
CROs
Providing a versatile next-generation heterogeneity platform for robust data generation, deeply-characterised with matched multi-omic and clinical data
Oncology & Biotech
Supplying a cost-effective, translatable tumour heterogeneity platform with on-hand expert support, permitting generation of reproducible and robust outputs
Academic Researchers
Enhancing clinical translatability of model systems, providing tractability in mechanistic or tumour evolution studies
PREDICTIVE POWER
Advanced Tumour Modelling
We supply versatile, robust, deeply-characterised models representing the full tumour and patient landscape, including rare and resistant subtypes, to provide unmatched biological relevance and predictive power.
Representative
Capture tumour heterogeneity and resistance with multi-region sampled models.
Scalable
Apply across workflows with whole-tumour representation for seamless research.
Characterised
Instantly query 100+ tumour samples with our intuitive user interface.
Tractable
Monitor tumour evolution with unmatched precision using MRI-lineage tracing.
Support
License models, access CRO services, and consult experts for translatable research.
TAKE OUR SURVEY
Help shape the future of treating cancer. Share your expertise and insights.
We are developing the next generation of cancer research platforms. We want to make sure they are designed in tune with the needs of CROs, Big Pharma, Biotechs and Academics. We would love to hear your insights and expertise, to help shape the future of treating cancer.
PREDICTIVE POWER
Our Specialist Team
Our multi-disciplinary team has experience from benchtop to bedside – in clinical, industrial, manufacturing, and academic settings. Get in touch and leverage our know-how, accumulated over a combined 40 years.
CONTACT US
Have Questions? Get in touch!
Interested in being an early adopter, early user, or co-developer? We would love to hear your insights, ideas, and collaboration opportunities as we refine our innovative platform for heterogeneous cancer research. Whether you’re a researcher, clinician, or industry partner, your expertise can help shape the future of pre-clinical cancer models.